Table of Contents
International Journal of Evolutionary Biology
Volume 2015, Article ID 179791, 10 pages
http://dx.doi.org/10.1155/2015/179791
Review Article

An Evolutionary Perspective of Nutrition and Inflammation as Mechanisms of Cardiovascular Disease

Department of Physiology, Instituto Nacional de Cardiología “Ignacio Chávez”, 14080 Mexico City, DF, Mexico

Received 26 October 2015; Accepted 12 November 2015

Academic Editor: Andres Moya

Copyright © 2015 María Esther Rubio-Ruiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Ridker, “On evolutionary biology, inflammation, infection, and the causes of atherosclerosis,” Circulation, vol. 105, no. 1, pp. 2–4, 2002. View at Google Scholar · View at Scopus
  2. J. C. K. Wells, “Ethnic variability in adiposity and cardiovascular risk: the variable disease selection hypothesis,” International Journal of Epidemiology, vol. 38, no. 1, pp. 63–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-M. Fernández-Real and W. Ricart, “Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness,” Diabetologia, vol. 42, no. 11, pp. 1367–1374, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Pickup, “Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes,” Diabetes Care, vol. 27, no. 3, pp. 813–823, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Stern, “Diabetes and cardiovascular disease: the common soil hypothesis,” Diabetes, vol. 44, no. 4, pp. 369–374, 1995. View at Google Scholar · View at Scopus
  7. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. Hak, C. D. A. Stehouwer, M. L. Bots et al., “Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 8, pp. 1986–1991, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kobayasi, E. H. Akamine, A. P. Davel, M. A. M. Rodrigues, C. R. O. Carvalho, and L. V. Rossoni, “Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice,” Journal of Hypertension, vol. 28, no. 10, pp. 2111–2119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. P. Da Silva, “Sex hormones and glucocorticoids: interactions with the immune system,” Annals of the New York Academy of Sciences, vol. 876, pp. 102–118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Bauer, “Stress, glucocorticoids and ageing of the immune system,” Stress, vol. 8, no. 1, pp. 69–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Franceschi, M. Capri, D. Monti et al., “Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans,” Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 92–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Pijl, “Obesity: evolution of a symptom of Affuence. How food has shaped our existence,” Netherlands Journal of Medicine, vol. 69, no. 4, pp. 159–166, 2011. View at Google Scholar · View at Scopus
  15. K. Milton, “Back to basics: why foods of wild primates have relevance for modern human health,” Nutrition, vol. 16, no. 7-8, pp. 480–483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. A. P. Simopoulos, “Evolutionary aspects of diet, essential fatty acids and cardiovascular disease,” European Heart Journal Supplements, vol. 3, supplement D, pp. 8–21, 2001. View at Google Scholar
  17. N. Mann, “Dietary lean red meat and human evolution,” European Journal of Nutrition, vol. 39, no. 2, pp. 71–79, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. H. L. Fehm, W. Kern, and A. Peters, “The selfish brain: competition for energy resources,” Progress in Brain Research, vol. 153, pp. 129–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Guarner and R. Alvarez-Buylla, “Changes in brain glucose retention produced by the stimulation of an insulin-sensitive reflexogenic zone in rats,” Journal of the Autonomic Nervous System, vol. 34, no. 1, pp. 89–94, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. W. A. Banks, “Role of the blood-brain barrier in the evolution of feeding and cognition,” Annals of the New York Academy of Sciences, vol. 1264, no. 1, pp. 13–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. G. Harrison, T. J. Guzik, H. E. Lob et al., “Inflammation, immunity, and hypertension,” Hypertension, vol. 57, no. 2, pp. 132–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Batuman, “Salt and hypertension: an evolutionary perspective,” Journal of Hypertension, vol. 1, no. 3, article e106, 2012. View at Google Scholar
  23. G. Sánchez-Torres, “Bipedalismo y el síndrome de intolerancia al ortostatismo,” in Cardiología Evolutiva, G. Sanchez Torres and V. Guarner, Eds., pp. 127–139, Lulu, Raleigh, NC, USA, 2012. View at Google Scholar
  24. S. Mäkinen, P. Skrobuk, Y. H. Nguyen, and H. Koistinen, “Mechanisms of insulin resistance,” Duodecim, vol. 129, no. 20, pp. 2115–2122, 2013. View at Google Scholar · View at Scopus
  25. B. Bogin, “From caveman cuisine to fast food: the evolution of human nutrition,” Growth Hormone and IGF Research, vol. 8, supplement 2, pp. 79–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. J. V. Neel, “Diabetes mellitus: a ‘thrifty’ genotype rendered detrimental by ‘progress’?” The American Journal of Human Genetics, vol. 14, pp. 353–362, 1962. View at Google Scholar · View at Scopus
  27. C. N. Hales and D. J. P. Barker, “Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis,” Diabetologia, vol. 35, no. 7, pp. 595–601, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Colagiuri and J. B. Miller, “The ‘carnivore connection’—evolutionary aspects of insulin resistance,” The European Journal of Clinical Nutrition, vol. 56, supplement 1, pp. S30–S35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Amen-Ra, “Humans are evolutionarily adapted to caloric restriction resulting from ecologically dictated dietary deprivation imposed during the Plio-Pleistocene period,” Medical Hypotheses, vol. 66, no. 5, pp. 978–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Aguilar-Salinas, S. Canizales-Quinteros, R. Rojas-Martínez et al., “Hypoalphalipoproteinemia in populations of Native American ancestry: an opportunity to assess the interaction of genes and the environment,” Current Opinion in Lipidology, vol. 20, no. 2, pp. 92–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Acuña-Alonzo, T. Flores-Dorantes, J. K. Kruit et al., “A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans,” Human Molecular Genetics, vol. 19, no. 14, pp. 2877–2885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. T. Villarreal-Molina, C. A. Aguilar-Salinas, M. Rodríguez-Cruz et al., “The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities,” Diabetes, vol. 56, no. 7, pp. 1881–1887, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Hünemeier, C. E. G. Amorim, S. Azevedo et al., “Evolutionary responses to a constructed niche: ancient mesoamericans as a model of gene-culture coevolution,” PLoS ONE, vol. 7, no. 6, Article ID e38862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. T. Hattersley and J. E. Tooke, “The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease,” The Lancet, vol. 353, no. 9166, pp. 1789–1792, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. J. C. K. Wells, “The thrifty phenotype hypothesis: thrifty offspring or thrifty mother?” Journal of Theoretical Biology, vol. 221, no. 1, pp. 143–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. T. A. M. Harrington, E. L. Thomas, G. Frost, N. Modi, and J. D. Bell, “Distribution of adipose tissue in the newborn,” Pediatric Research, vol. 55, no. 3, pp. 437–441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. C. Stearns, R. M. Nesse, and D. Haig, “Introducing evolutionary thinking for medicine,” in Evolution in Health and Disease, S. C. Stearns and J. C. Koella, Eds., pp. 3–15, Oxford University Press, Oxford, UK, 2008. View at Google Scholar
  38. J. C. K. Wells, “The evolution of human fatness and susceptibility to obesity: an ethological approach,” Biological Reviews of the Cambridge Philosophical Society, vol. 81, no. 2, pp. 183–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. E. Schneider, “Energy balance and reproduction,” Physiology & Behavior, vol. 81, no. 2, pp. 289–317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. C. W. Kuzawa, “Adipose tissue in human infancy and childhood: an evolutionary perspective,” The American Journal of Physical Anthropology, supplement 27, pp. 177–209, 1998. View at Google Scholar · View at Scopus
  41. N. G. Norgan, “The beneficial effects of body fat and adipose tissue in humans,” International Journal of Obesity, vol. 21, no. 9, pp. 738–746, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Lord, “Role of leptin in immunology,” Nutrition Reviews, vol. 60, no. 10, part 2, pp. S35–S38, 2002. View at Google Scholar · View at Scopus
  43. J. R. Speakman, “A nonadaptive scenario explaining the genetic predisposition to obesity: the ‘predation release’ hypothesis,” Cell Metabolism, vol. 6, no. 1, pp. 5–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. R. Speakman, “Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the ‘drifty gene’ hypothesis,” The International Journal of Obesity, vol. 32, no. 11, pp. 1611–1617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. J. Kallus and L. J. Brandt, “The intestinal microbiota and obesity,” Journal of Clinical Gastroenterology, vol. 46, no. 1, pp. 16–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Manco, L. Putignani, and G. F. Bottazzo, “Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk,” Endocrine Reviews, vol. 31, no. 6, pp. 817–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. N. S. Scrimshaw, “Energy cost of communicable diseases in infancy and childhood,” in Activity, Energy Expenditure and Energy Requirements of Infants and Children, B. Schurch and N. S. Scrimshaw, Eds., pp. 215–237, International Dietary Energy Consultancy Group (IDECG), Vienna, Austria, 1990. View at Google Scholar
  48. W. R. Beisel, “Metabolic response to infection,” Annual Review of Medicine, vol. 26, pp. 9–20, 1975. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Espinola-Klein, H. J. Rupprecht, S. Blankenberg et al., “Impact of infectious burden on extent and long-term prognosis of atherosclerosis,” Circulation, vol. 105, no. 1, pp. 15–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. G. A. W. Rook, “Hygiene hypothesis and autoimmune diseases,” Clinical Reviews in Allergy & Immunology, vol. 42, no. 1, pp. 5–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. D. T. A. Eisenberg, “An evolutionary review of human telomere biology: the thrifty telomere hypothesis and notes on potential adaptive paternal effects,” The American Journal of Human Biology, vol. 23, no. 2, pp. 149–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. U. Ravnskov and K. S. McCully, “Infections may be causal in the pathogenesis of atherosclerosis,” The American Journal of the Medical Sciences, vol. 344, no. 5, pp. 391–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Vendrell, M. Broch, N. Vilarrasa et al., “Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity,” Obesity Research, vol. 12, no. 6, pp. 962–971, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. J. I. Beier, L. Guo, C. von Montfort, J. P. Kaiser, S. Joshi-Barve, and G. E. Arteel, “New role of resistin in lipopolysaccharide-induced liver damage in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 801–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Jager, T. Grémeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti, “Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression,” Endocrinology, vol. 148, no. 1, pp. 241–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Park, V. Wong, X. Guan, A. I. Oprescu, and A. Giacca, “Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo,” Journal of Endocrinology, vol. 195, no. 2, pp. 323–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Boden, “Fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver,” Current Diabetes Reports, vol. 6, no. 3, pp. 177–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. G. E. Demas and S. Sakaria, “Leptin regulates energetic tradeoffs between body fat and humoural immunity,” Proceedings of the Royal Society B: Biological Sciences, vol. 272, no. 1574, pp. 1845–1850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Sukumar, H. Viswambharan, H. Imrie et al., “Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction,” Diabetes, vol. 62, no. 6, pp. 2130–2134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. D. M. Ansley and B. Wang, “Oxidative stress and myocardial injury in the diabetic heart,” Journal of Pathology, vol. 229, no. 2, pp. 232–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Wu, K. Chen, and K. J. Williams, “The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia,” Current Opinion in Lipidology, vol. 23, no. 4, pp. 334–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Zhang, K.-H. Krause, I. Xenarios, T. Soldati, and B. Boeckmann, “Evolution of the Ferric Reductase Domain (FRD) Superfamily: modularity, functional diversification, and signature motifs,” PLoS ONE, vol. 8, no. 3, Article ID e58126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. I. Malik, J. Danesh, P. Whincup et al., “Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis,” The Lancet, vol. 358, no. 9286, pp. 971–975, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. R. R. S. Packard and P. Libby, “Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction,” Clinical Chemistry, vol. 54, no. 1, pp. 24–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Ross, “Atherosclerosis: an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. L. F. Van Gaal, I. L. Mertens, and C. E. De Block, “Mechanisms linking obesity with cardiovascular disease,” Nature, vol. 444, no. 7121, pp. 875–880, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Anfossi, I. Russo, and M. Trovati, “Platelet dysfunction in central obesity,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 6, pp. 440–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. R. H. Straub, “Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology,” Journal of Molecular Medicine, vol. 90, no. 5, pp. 523–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Nakajima, S. Wooding, T. Sakagami et al., “Natural Selection and Population History in the Human Angiotensinogen Gene (AGT): 736 complete AGT sequences in chromosomes from around the world,” American Journal of Human Genetics, vol. 74, no. 5, pp. 898–916, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. X. Li, X. Sun, L. Jin, and F. Xue, “Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis,” The European Journal of Human Genetics, vol. 19, no. 9, pp. 1002–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Niemitz, “The evolution of the upright posture and gait—a review and a new synthesis,” Naturwissenschaften, vol. 97, no. 3, pp. 241–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Roach, L. Racioppi, C. D. Jones, and A. M. Masci, “Phylogeny of toll-like receptor signaling: adapting the innate response,” PLoS ONE, vol. 8, no. 1, Article ID e54156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Fornůsková, M. Vinkler, M. Pagès et al., “Contrasted evolutionary histories of two Toll-like receptors (Tlr4 and Tlr7) in wild rodents (MURINAE),” BMC Evolutionary Biology, vol. 13, article 194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Song, P. Jin, S. Qin, L. Chen, and F. Ma, “The evolution and origin of animal Toll-Like receptor signaling pathway revealed by network-level molecular evolutionary analyses,” PLoS ONE, vol. 7, no. 12, Article ID e51657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. G. F. Bomfim, R. A. Dos Santos, M. A. Oliveira et al., “Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats,” Clinical Science, vol. 122, no. 11, pp. 535–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. M. R. Dasu, S. Ramirez, and R. R. Isseroff, “Toll-like receptors and diabetes: a therapeutic perspective,” Clinical Science, vol. 122, no. 5, pp. 203–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. B. T. Bikman and S. A. Summers, “Ceramides as modulators of cellular and whole-body metabolism,” The Journal of Clinical Investigation, vol. 121, no. 11, pp. 4222–4230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Broering, M. Lu, and J. F. Schlaak, “Role of toll-like receptors in liver health and disease,” Clinical Science, vol. 121, no. 10, pp. 415–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Ballestri, A. Lonardo, S. Bonapace, C. D. Byrne, P. Loria, and G. Targher, “Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1724–1745, 2014. View at Publisher · View at Google Scholar · View at Scopus